POU4F2 and cancer: At the protein level, AngII treatment causes preferential increase in the Brn-3b(s) isoform and while the roles for the distinct Brn-3b isoforms are still unclear, high levels of Brn-3b(s) protein is strongly associated with increased proliferative and oncogenic potential cancer cells34,35.